Rituximab as a first-line treatment in pediatric neuromyelitis optica spectrum disorder

被引：5
|
作者：
Olivieri, Giorgia [1 ]
Nociti, Viviana [2 ,3 ]
Iorio, Raffaele [2 ]
Stefanini, Maria Chiara [1 ]
Losavio, Francesco Antonio [2 ]
Mirabella, Massimiliano [2 ]
Mariotti, Paolo [1 ]
机构：
[1] Catholic Univ, Unit Child Neuropsychiat, Rome, Italy
[2] Catholic Univ, Inst Neurol, Dept Geriatr Neurosci & Orthoped, I-00168 Rome, Italy
[3] Don C Gnocchi Fdn Onlus, Milan, Italy
来源：
NEUROLOGICAL SCIENCES | 2015年 / 36卷 / 12期
关键词：
Pediatric NMOSD; Aquaporin-4; Rituximab; First-line therapy;
D O I：
10.1007/s10072-015-2368-x
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：2301 / 2302
页数：2
相关论文
共 50 条
  • [1] Rituximab as a first-line treatment in pediatric neuromyelitis optica spectrum disorder
    Giorgia Olivieri
    Viviana Nociti
    Raffaele Iorio
    Maria Chiara Stefanini
    Francesco Antonio Losavio
    Massimiliano Mirabella
    Paolo Mariotti
    Neurological Sciences, 2015, 36 : 2301 - 2302
  • [2] Rituximab in Neuromyelitis Optica Spectrum Disorders: Why Not as First-Line Therapy
    Kim, Su-Hyun
    Kim, Ho Jin
    JAMA NEUROLOGY, 2017, 74 (04) : 482 - 482
  • [3] Azathioprine for first-line treatment in neuromyelitis optica and neuromyelitis optica spectrum disorders: efficacy and safety
    Kim, J. H.
    Park, M. S.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 91 - 91
  • [4] Rituximab monitoring and redosing in pediatric neuromyelitis optica spectrum disorder
    Nosadini, Margherita
    Alper, Gulay
    Riney, Catherine J.
    Benson, Leslie A.
    Mohammad, Shekeeb S.
    Ramanathan, Sudarshini
    Nolan, Melinda
    Appleton, Richard
    Leventer, Richard J.
    Deiva, Kumaran
    Brilot, Fabienne
    Gorman, Mark P.
    Waldman, Amy T.
    Banwell, Brenda
    Dale, Russell C.
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2016, 3 (01):
  • [5] Rituximab as First-Line or Escalation Immunotherapy in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder
    Engels, Daniel
    Rocchi, Chiara
    Forcadela, Mirasol
    Havla, Joachim
    Ringelstein, Marius
    Huemmert, Martin W.
    Giglhuber, Katrin
    Berthele, Achim
    Trebst, Corinna
    Aktas, Orhan
    Huda, Saif
    Kuempfel, Tania
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 706 - 707
  • [6] Rituximab as first-line therapy in neuromyelitis optica: efficiency and tolerability
    Zephir, H.
    Bernard-Valnet, R.
    Lebrun-Frenay, C.
    Outteryck, O.
    Audoin, B.
    Bourre, B.
    Pittion, S.
    Wiertlewski, S.
    Ouallet, J. -C.
    Ciron, J.
    Neau, J. -P.
    Clavelou, P.
    Marignier, R.
    Brassat, D.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 243 - 244
  • [7] Predictors of Response to First-Line Immunosuppressive Therapy in Neuromyelitis Optica Spectrum Disorder
    Kim, Su-Hyun
    Hyun, Jae-Won
    Jo, Hyo-Jin
    Joung, AeRan
    Kim, Ho Jin
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (02) : 314 - 314
  • [8] Rituximab as first-line therapy in neuromyelitis optica: efficiency and tolerability
    Zephir, Helene
    Bernard-Valnet, Raphael
    Lebrun, Christine
    Outteryck, Olivier
    Audoin, Bertrand
    Bourre, Bertrand
    Pittion, Sophie
    Wiertlewski, Sandrine
    Ouallet, Jean Christophe
    Neau, Jean-Philippe
    Ciron, Jonathan
    Clavelou, Pierre
    Marignier, Romain
    Brassat, David
    JOURNAL OF NEUROLOGY, 2015, 262 (10) : 2329 - 2335
  • [9] Rituximab as first-line therapy in neuromyelitis optica: efficiency and tolerability
    Hélène Zéphir
    Raphaël Bernard-Valnet
    Christine Lebrun
    Olivier Outteryck
    Bertrand Audoin
    Bertrand Bourre
    Sophie Pittion
    Sandrine Wiertlewski
    Jean Christophe Ouallet
    Jean-Philippe Neau
    Jonathan Ciron
    Pierre Clavelou
    Romain Marignier
    David Brassat
    Journal of Neurology, 2015, 262 : 2329 - 2335
  • [10] Pediatric Neuromyelitis Optica Spectrum Disorder
    Poisson, Kelsey
    Moeller, Karen
    Fisher, Kristen S.
    SEMINARS IN PEDIATRIC NEUROLOGY, 2023, 46 : 1 - 8
12345